Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2010 1
2012 5
2013 3
2016 1
2017 1
2018 1
2019 1
2020 5
2021 15
2022 18
2023 13

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Versican promotes T helper 17 cytotoxic inflammation and impedes oligodendrocyte precursor cell remyelination.
Ghorbani S, Jelinek E, Jain R, Buehner B, Li C, Lozinski BM, Sarkar S, Kaushik DK, Dong Y, Wight TN, Karimi-Abdolrezaee S, Schenk GJ, Strijbis EM, Geurts J, Zhang P, Ling CC, Yong VW. Ghorbani S, et al. Among authors: strijbis em. Nat Commun. 2022 May 4;13(1):2445. doi: 10.1038/s41467-022-30032-0. Nat Commun. 2022. PMID: 35508608 Free PMC article.
Natalizumab discontinuation in a Dutch real-world cohort.
Coerver EME, Wessels MHJ, van Lierop ZYG, van Kempen ZLE, Killestein J, Strijbis EMM. Coerver EME, et al. Among authors: strijbis emm. Mult Scler Relat Disord. 2021 Jul;52:102974. doi: 10.1016/j.msard.2021.102974. Epub 2021 Apr 24. Mult Scler Relat Disord. 2021. PMID: 33990055
Is MS affecting the CNS only? Lessons from clinic to myelin pathophysiology.
Oudejans E, Luchicchi A, Strijbis EMM, Geurts JJG, van Dam AM. Oudejans E, et al. Among authors: strijbis emm. Neurol Neuroimmunol Neuroinflamm. 2020 Nov 24;8(1):e914. doi: 10.1212/NXI.0000000000000914. Print 2021 Jan. Neurol Neuroimmunol Neuroinflamm. 2020. PMID: 33234720 Free PMC article. Review.
The wearing-off phenomenon of ocrelizumab in patients with multiple sclerosis.
Toorop AA, van Lierop ZYGJ, Strijbis EMM, Teunissen CE, Barkhof F, Uitdehaag BMJ, van Kempen ZLE, Killestein J. Toorop AA, et al. Among authors: strijbis emm. Mult Scler Relat Disord. 2022 Jan;57:103364. doi: 10.1016/j.msard.2021.103364. Epub 2021 Nov 1. Mult Scler Relat Disord. 2022. PMID: 35158470 Free article.
47 results